Global Companion Diagnostics Market to Reach a New Threshold of Growth: Expected to Reach USD 7.8 Billion in 2027

NEXT STORY
Kura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO-539
PREV STORY
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Global Companion Diagnostics Market to Reach a New Threshold of Growth: Expected to Reach USD 7.8 Billion in 2027

NEXT STORY
Kura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO-539
PREV STORY
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PolyPid Initiates SHIELD II: Second Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections

author_avatar
NASDAQ Market News

Genocea to Present at the Cowen and Company 37th Annual Health Care Conference

CAMBRIDGE, Mass., March 01, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Veru Announces Positive Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in Men with Metastatic Castration Resistant Prostate Cancer Presented at the 2021 ASCO Annual Meeting

author_avatar
NASDAQ Market News